Valuation: Bioneer Corporation

Market Cap 218B 157M 135M 127M 116M 218M 14.99B 219M 1.5B 580M 7.56B 590M 577M 25.04B P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 232B 167M 143M 135M 123M 232M 15.94B 233M 1.59B 618M 8.04B 628M 614M 26.64B EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
82.04%
Yield 2024 *
-
Yield 2025 -
1 day-7.14%
1 week+17.68%
Current month+31.85%
1 month+30.41%
3 months-18.43%
6 months-34.80%
Current year-34.75%
1 week 8,070
Extreme 8070
10,920
1 month 5,470
Extreme 5470
10,920
Current year 5,470
Extreme 5470
14,210
1 year 5,470
Extreme 5470
15,640
3 years 5,470
Extreme 5470
44,350
5 years 5,470
Extreme 5470
98,800
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 1992-07-31
Corporate Officer/Principal 51 2025-03-30
Corporate Officer/Principal 62 2024-03-27
Director TitleAgeSince
Director/Board Member 64 2011-02-17
Director/Board Member 62 1997-04-30
Director/Board Member 63 2000-01-31
Date Insider Type Main position Quantity % Market Cap.
6/12/25 Fiscal year

Director

2,625 0.0102%
3/3/25 Buy

Chief Executive Officer

3,000 0.0116%
1/22/25 Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-7.14%+17.68%-40.91%-79.83% 155M
+3.31%-3.70%+61.03%+103.64% 71.35B
+2.09%+2.28%+49.95%+91.30% 64.17B
-1.31%-0.50%+7.41%-4.29% 28.65B
-3.01%-0.81%+55.04%+8.82% 27.33B
+0.40%-4.80%-5.89%+469.55% 27.06B
-1.68%+0.33%+36.86%-16.09% 20.47B
+1.02%+6.43%+269.42%+420.34% 19.36B
-0.29%-2.72%+11.89%+536.20% 15.96B
-1.09%+3.14%+46.32%+155.12% 14.05B
Average -0.78%+2.70%+49.11%+168.48% 28.85B
Weighted average by Cap. +0.78%+3.29%+55.18%+154.60%

Financials

2024 2025
Net sales 294B 212M 182M 171M 156M 294M 20.22B 296M 2.02B 783M 10.2B 796M 779M 33.79B 330B 238M 204M 192M 175M 331M 22.71B 332M 2.27B 880M 11.46B 894M 875M 37.94B
Net income -20.58B -14.85M -12.74M -11.96M -10.92M -20.62M -1.42B -20.71M -142M -54.85M -714M -55.74M -54.53M -2.37B -2.81B -2.03M -1.74M -1.63M -1.49M -2.82M -194M -2.83M -19.34M -7.5M -97.63M -7.62M -7.45M -323M
Net Debt -20.54B -14.81M -12.71M -11.93M -10.9M -20.57M -1.41B -20.67M -141M -54.73M -713M -55.62M -54.41M -2.36B 13.9B 10.02M 8.6M 8.08M 7.38M 13.92M 956M 13.99M 95.56M 37.03M 482M 37.64M 36.82M 1.6B
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
392
Date Price Change Volume
26-08-26 ₩8,440.00 +1.44% 266,522
26-08-25 ₩8,320.00 -7.14% 369,713
26-08-24 ₩8,960.00 -0.78% 579,228
26-08-21 ₩9,030.00 -4.95% 894,806
26-08-20 ₩9,500.00 +3.37% 2,065,842
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A064550 Stock